Diphenoxylate Hydrochloride And Atropine Sulfate Tablet
Product Images NDC 62559-490

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Diphenoxylate Hydrochloride And Atropine Sulfate (NDC 62559-490). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atrop-structure.jpg (Atrop Structure)

FDA Label Image

Diphen-structure.jpg (Diphen Structure)

FDA Label Image

Ani.jpg (Ani)

FDA Label Image

Image 01

Image 01
This is a medication for oral use only, and it is available only with a prescription. Each tablet contains 2.5 mg of diphenoxylate hydrochloride USP and 0.025 mg of atropine sulfate USP. The tablet should be stored in a controlled room temperature. It is not intended for use in children under 6 years of age. The medication has the potential to become habit-forming, and patients should be warned not to exceed the recommended dosage. It also should be kept out of reach of children in a well-closed container. The prescribing information should be consulted for dosage. The medication is manufactured by ANI Pharmaceuticals, Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.